Robert Madelin is the Chairman of FIPRA International, a micro-multinational public affairs consultancy. Before joining FIPRA in 2016, Robert served for over 35 years as a UK and then a European Union public servant. He was a trade negotiator for over 20 years; and a European Commission Director General from 2004, notably on health and tech innovation, with regulatory responsibilities for the, food chain, GMOs, media content and telecomms. British by birth, French by marriage, Robert was educated at the Royal Grammar School, High Wycombe and Magdalen College, Oxford, as well as at the French Ecole Nationale d’Administration. He has been a visiting Fellow at both the Oxford University Department of Politics and International Relations and the Cambridge University Centre for Science and Policy. Robert currently also sits on the International Advisory Council of Teladoc Health, Inc, a US-headquartered telemedicine company. He is a non-executive director at Médisanté Group AG, a Swiss medtech startup and a consultant to PlusValue Advisory Ltd, which specialises in social impact investing. Robert is author of 'Opportunity Now: Europe's mission to innovate' (2016), ‘An ethical framework for a good AI society’ (2018) and ‘On good AI governance’ (2019). Robert is an Honorary Fellow of the Royal College of Physicians of London and an Honorary Doctor of the University of Edinburgh. Based in Brussels, Robert sees the Eurostar Triangle as home territory, venturing further afield for business and pleasure.